“…To date, only a few, small, heterogeneous series of cases of SMPTCL have been published [3,4,5,6,7,8]; thus, clinical features, prognosis and optimal treatment modalities are not well characterized. In this context, it should be underlined that precise diagnostic criteria for the differentiation of SMPTCL from benign lesions (pseudolymphomas) are lacking, and cases with clinicopathological features overlapping with those of SMPTCL have been reported under different names, including ‘solitary lymphomatous papule, nodule or tumour’ [13], ‘cutaneous lymphoid hyperplasia’ [14], ‘solitary non-epidermotropic T-cell pseudolymphoma’ [15], ‘pseudolymphomatous folliculitis’ [16, 17] and ‘unilesional mycosis fungoides’ [18]. Cases reported recently as ‘indolent CD8+ lymphoid proliferation of the ear’ [19] or ‘pleomorphic CD8+ small/medium size cutaneous T-cell lymphoma’ [20] may represent a phenotypic variant of the same pathological process, too.…”